Tirzepatide’s Glowing Obesity Data Steal Show On Lilly’s Earnings Call

 
• By Joseph Haas
Head to head battle
Tirzepatide data in obesity may set up head-to-head battle between Lilly, Novo Nordisk • Source: Alamy

More from Earnings

More from Business